Peter H. Michelson - Publications

Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.

Journal: The Lancet. Respiratory medicine

Published: October 25, 2024

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 16, 2019

Ready-to-Use Supplemental Food for Nutritional Supplementation in Cystic Fibrosis.

Journal: Current developments in nutrition

Published: October 22, 2018

Reduction in Mortality Following Pediatric Rapid Response Team Implementation.

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Published: March 13, 2018

Official American Thoracic Society technical standards: flexible airway endoscopy in children.

Journal: American journal of respiratory and critical care medicine

Published: May 02, 2015

Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 06, 2014

Lung transplant is a viable treatment option for patients with congenital and acquired pulmonary vein stenosis.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: November 16, 2012